Literature DB >> 20336642

Understanding distress and distressing experiences in patients living with multiple myeloma: an exploratory study.

Barbara Potrata1, Jim Cavet, Susan Blair, Tracy Howe, Alex Molassiotis.   

Abstract

PURPOSE: The aim of this study was to gain greater insight into the symptoms and distressing experiences of patients living with myeloma.
METHODS: A qualitative interview evaluation of distressing experiences in patients with myeloma, following a grounded theory approach, was used. Sampling was purposive, with particular attention to diversity in age and ethnic minority patients.
RESULTS: Fifteen patients were interviewed. Key findings suggest that (a) many individual symptoms were not considered as particularly distressing beyond the acute phase of the disease and its treatment, except when they occurred in a context that was threatening to the patients; (b) visible symptoms that showed to other people one's disease condition may be particularly distressing, and (c) the conditioning phase of the transplant was particularly stressful and a violation to one's body, described by some patients as 'being somehow dead'.
CONCLUSION: The personal meaning ascribed to symptoms and treatments as well as the context in which they occur are important determinants of distress. Such patient meanings and contexts should be explored by health professionals in-depth, in order to prepare patients for the experience and support them more fully.
Copyright © 2010 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 20336642     DOI: 10.1002/pon.1715

Source DB:  PubMed          Journal:  Psychooncology        ISSN: 1057-9249            Impact factor:   3.894


  14 in total

1.  Physical activity participation and barriers for people with multiple myeloma.

Authors:  Melinda Craike; Kaye Hose; Patricia M Livingston
Journal:  Support Care Cancer       Date:  2012-10-02       Impact factor: 3.603

2.  A qualitative study of the ramifications of rash from epidermal growth factor receptor (EGFR) inhibitors.

Authors:  Shawnta Coleman; Irina Kovtun; Phuong L Nguyen; Mark Pittelkow; Aminah Jatoi
Journal:  Psychooncology       Date:  2010-09-23       Impact factor: 3.894

3.  Development of a conceptual model to illustrate the impact of multiple myeloma and its treatment on health-related quality of life.

Authors:  R Baz; H M Lin; A-M Hui; R D Harvey; K Colson; K Gallop; P Swinburn; J Laubach; D Berg; P Richardson
Journal:  Support Care Cancer       Date:  2015-02-24       Impact factor: 3.603

4.  Health-Related Quality-of-Life Results From the Open-Label, Randomized, Phase III ASPIRE Trial Evaluating Carfilzomib, Lenalidomide, and Dexamethasone Versus Lenalidomide and Dexamethasone in Patients With Relapsed Multiple Myeloma.

Authors:  A Keith Stewart; Meletios A Dimopoulos; Tamás Masszi; Ivan Špička; Albert Oriol; Roman Hájek; Laura Rosiñol; David S Siegel; Ruben Niesvizky; Andrzej J Jakubowiak; Jesus F San-Miguel; Heinz Ludwig; Jacqui Buchanan; Kim Cocks; Xinqun Yang; Biao Xing; Naseem Zojwalla; Margaret Tonda; Philippe Moreau; Antonio Palumbo
Journal:  J Clin Oncol       Date:  2016-11-10       Impact factor: 44.544

5.  'It is a journey of discovery': living with myeloma.

Authors:  Rosslyn de Wet; Heather Lane; Anil Tandon; Bradley Augustson; David Joske
Journal:  Support Care Cancer       Date:  2018-10-27       Impact factor: 3.603

6.  Improving the assessment of quality of life in the clinical care of myeloma patients: the development and validation of the Myeloma Patient Outcome Scale (MyPOS).

Authors:  Thomas R Osborne; Christina Ramsenthaler; Stephen A Schey; Richard J Siegert; Polly M Edmonds; Irene J Higginson
Journal:  BMC Cancer       Date:  2015-04-14       Impact factor: 4.430

7.  Electronic patient self-Reporting of Adverse-events: Patient Information and aDvice (eRAPID): a randomised controlled trial in systemic cancer treatment.

Authors:  Kate Absolom; Patricia Holch; Lorraine Warrington; Faye Samy; Claire Hulme; Jenny Hewison; Carolyn Morris; Leon Bamforth; Mark Conner; Julia Brown; Galina Velikova
Journal:  BMC Cancer       Date:  2017-05-08       Impact factor: 4.430

8.  Interrupted Identities: Autologous Stem Cell Transplant in Patients With Multiple Myeloma.

Authors:  Sean N Halpin; Michael Konomos; Ivey Jowers
Journal:  J Patient Exp       Date:  2021-03-03

9.  Understanding what matters most to people with multiple myeloma: a qualitative study of views on quality of life.

Authors:  Thomas R Osborne; Christina Ramsenthaler; Susanne de Wolf-Linder; Stephen A Schey; Richard J Siegert; Polly M Edmonds; Irene J Higginson
Journal:  BMC Cancer       Date:  2014-07-09       Impact factor: 4.430

10.  Living With Multiple Myeloma: A Focus Group Study of Unmet Needs and Preferences for Survivorship Care.

Authors:  Leanne Monterosso; Karen Taylor; Violet Platt; Elizabeth Lobb; Toni Musiello; Caroline Bulsara; Kendall Stratton; David Joske; Meinir Krishnasamy
Journal:  J Patient Exp       Date:  2017-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.